Global Anti-infective API Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Global Anti-infective API Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Page: 115

Published Date: 08 Jan 2024

Category: Chemical & Material

PDF Download

Get FREE Sample

Customize Request

  • sp_icon1 sp_icon1_b Description
  • sp_icon2 sp_icon2_b Table of Contents
  • sp_icon3 sp_icon3_b Table of Figures
  • sp_icon4 sp_icon4_b Research Methodology
  • sp_icon1 sp_icon1_b Companies Mentioned
  • sp_icon1 sp_icon1_b Related Reports
  • sp_icon1 sp_icon1_b Product Tags
btl

Description

According to our (Global Info Research) latest study, the global Anti-infective API market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

The Global Info Research report includes an overview of the development of the Anti-infective API industry chain, the market status of Antibacterial Drugs for Systemic Use (β-lactam Drugs, Macrolides), Antiviral Drugs for Systemic Use (β-lactam Drugs, Macrolides), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Anti-infective API.

Regionally, the report analyzes the Anti-infective API markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Anti-infective API market, with robust domestic demand, supportive policies, and a strong manufacturing base.

Key Features:
The report presents comprehensive understanding of the Anti-infective API market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Anti-infective API industry.

The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (Kiloton), revenue generated, and market share of different by Type (e.g., β-lactam Drugs, Macrolides).

Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Anti-infective API market.

Regional Analysis: The report involves examining the Anti-infective API market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.

Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Anti-infective API market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.

The report also involves a more granular approach to Anti-infective API:
Company Analysis: Report covers individual Anti-infective API manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.

Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Anti-infective API This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Antibacterial Drugs for Systemic Use, Antiviral Drugs for Systemic Use).

Technology Analysis: Report covers specific technologies relevant to Anti-infective API. It assesses the current state, advancements, and potential future developments in Anti-infective API areas.

Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Anti-infective API market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.

Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.

Market Segmentation
Anti-infective API market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.

Market segment by Type
β-lactam Drugs
Macrolides
Carbapenems
Quinolones

Market segment by Application
Antibacterial Drugs for Systemic Use
Antiviral Drugs for Systemic Use
Antigen for Whole Body
Bacteria
Immune Serum and Immunoglobulin
Anti-mycobacterial Drugs
Vaccine
Other

Major players covered
North China Pharmaceutical
CSPC
Harbin Pharmaceutical Group Pharmaceutical General Factory
Henan Huaxing Pharmaceutical Factory
Sichuan Pharmaceutical Jiangxi Dongfeng Pharmaceutical
Zhangjiakou Diha Pharmaceutical
Shandong Lukang Medicine
Zhuhai United Laboratories
Lunan Pharmaceutical Group
Sandoz

Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Anti-infective API product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Anti-infective API, with price, sales, revenue and global market share of Anti-infective API from 2019 to 2024.
Chapter 3, the Anti-infective API competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Anti-infective API breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Anti-infective API market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Anti-infective API.
Chapter 14 and 15, to describe Anti-infective API sales channel, distributors, customers, research findings and conclusion.
btl

Table of Contents

1 Market Overview
1.1 Product Overview and Scope of Anti-infective API
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Anti-infective API Consumption Value by Type: 2019 Versus 2023 Versus 2030
1.3.2 β-lactam Drugs
1.3.3 Macrolides
1.3.4 Carbapenems
1.3.5 Quinolones
1.4 Market Analysis by Application
1.4.1 Overview: Global Anti-infective API Consumption Value by Application: 2019 Versus 2023 Versus 2030
1.4.2 Antibacterial Drugs for Systemic Use
1.4.3 Antiviral Drugs for Systemic Use
1.4.4 Antigen for Whole Body
1.4.5 Bacteria
1.4.6 Immune Serum and Immunoglobulin
1.4.7 Anti-mycobacterial Drugs
1.4.8 Vaccine
1.4.9 Other
1.5 Global Anti-infective API Market Size & Forecast
1.5.1 Global Anti-infective API Consumption Value (2019 & 2023 & 2030)
1.5.2 Global Anti-infective API Sales Quantity (2019-2030)
1.5.3 Global Anti-infective API Average Price (2019-2030)

2 Manufacturers Profiles
2.1 North China Pharmaceutical
2.1.1 North China Pharmaceutical Details
2.1.2 North China Pharmaceutical Major Business
2.1.3 North China Pharmaceutical Anti-infective API Product and Services
2.1.4 North China Pharmaceutical Anti-infective API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 North China Pharmaceutical Recent Developments/Updates
2.2 CSPC
2.2.1 CSPC Details
2.2.2 CSPC Major Business
2.2.3 CSPC Anti-infective API Product and Services
2.2.4 CSPC Anti-infective API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 CSPC Recent Developments/Updates
2.3 Harbin Pharmaceutical Group Pharmaceutical General Factory
2.3.1 Harbin Pharmaceutical Group Pharmaceutical General Factory Details
2.3.2 Harbin Pharmaceutical Group Pharmaceutical General Factory Major Business
2.3.3 Harbin Pharmaceutical Group Pharmaceutical General Factory Anti-infective API Product and Services
2.3.4 Harbin Pharmaceutical Group Pharmaceutical General Factory Anti-infective API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Harbin Pharmaceutical Group Pharmaceutical General Factory Recent Developments/Updates
2.4 Henan Huaxing Pharmaceutical Factory
2.4.1 Henan Huaxing Pharmaceutical Factory Details
2.4.2 Henan Huaxing Pharmaceutical Factory Major Business
2.4.3 Henan Huaxing Pharmaceutical Factory Anti-infective API Product and Services
2.4.4 Henan Huaxing Pharmaceutical Factory Anti-infective API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Henan Huaxing Pharmaceutical Factory Recent Developments/Updates
2.5 Sichuan Pharmaceutical Jiangxi Dongfeng Pharmaceutical
2.5.1 Sichuan Pharmaceutical Jiangxi Dongfeng Pharmaceutical Details
2.5.2 Sichuan Pharmaceutical Jiangxi Dongfeng Pharmaceutical Major Business
2.5.3 Sichuan Pharmaceutical Jiangxi Dongfeng Pharmaceutical Anti-infective API Product and Services
2.5.4 Sichuan Pharmaceutical Jiangxi Dongfeng Pharmaceutical Anti-infective API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Sichuan Pharmaceutical Jiangxi Dongfeng Pharmaceutical Recent Developments/Updates
2.6 Zhangjiakou Diha Pharmaceutical
2.6.1 Zhangjiakou Diha Pharmaceutical Details
2.6.2 Zhangjiakou Diha Pharmaceutical Major Business
2.6.3 Zhangjiakou Diha Pharmaceutical Anti-infective API Product and Services
2.6.4 Zhangjiakou Diha Pharmaceutical Anti-infective API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Zhangjiakou Diha Pharmaceutical Recent Developments/Updates
2.7 Shandong Lukang Medicine
2.7.1 Shandong Lukang Medicine Details
2.7.2 Shandong Lukang Medicine Major Business
2.7.3 Shandong Lukang Medicine Anti-infective API Product and Services
2.7.4 Shandong Lukang Medicine Anti-infective API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Shandong Lukang Medicine Recent Developments/Updates
2.8 Zhuhai United Laboratories
2.8.1 Zhuhai United Laboratories Details
2.8.2 Zhuhai United Laboratories Major Business
2.8.3 Zhuhai United Laboratories Anti-infective API Product and Services
2.8.4 Zhuhai United Laboratories Anti-infective API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Zhuhai United Laboratories Recent Developments/Updates
2.9 Lunan Pharmaceutical Group
2.9.1 Lunan Pharmaceutical Group Details
2.9.2 Lunan Pharmaceutical Group Major Business
2.9.3 Lunan Pharmaceutical Group Anti-infective API Product and Services
2.9.4 Lunan Pharmaceutical Group Anti-infective API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Lunan Pharmaceutical Group Recent Developments/Updates
2.10 Sandoz
2.10.1 Sandoz Details
2.10.2 Sandoz Major Business
2.10.3 Sandoz Anti-infective API Product and Services
2.10.4 Sandoz Anti-infective API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 Sandoz Recent Developments/Updates

3 Competitive Environment: Anti-infective API by Manufacturer
3.1 Global Anti-infective API Sales Quantity by Manufacturer (2019-2024)
3.2 Global Anti-infective API Revenue by Manufacturer (2019-2024)
3.3 Global Anti-infective API Average Price by Manufacturer (2019-2024)
3.4 Market Share Analysis (2023)
3.4.1 Producer Shipments of Anti-infective API by Manufacturer Revenue ($MM) and Market Share (%): 2023
3.4.2 Top 3 Anti-infective API Manufacturer Market Share in 2023
3.4.2 Top 6 Anti-infective API Manufacturer Market Share in 2023
3.5 Anti-infective API Market: Overall Company Footprint Analysis
3.5.1 Anti-infective API Market: Region Footprint
3.5.2 Anti-infective API Market: Company Product Type Footprint
3.5.3 Anti-infective API Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region
4.1 Global Anti-infective API Market Size by Region
4.1.1 Global Anti-infective API Sales Quantity by Region (2019-2030)
4.1.2 Global Anti-infective API Consumption Value by Region (2019-2030)
4.1.3 Global Anti-infective API Average Price by Region (2019-2030)
4.2 North America Anti-infective API Consumption Value (2019-2030)
4.3 Europe Anti-infective API Consumption Value (2019-2030)
4.4 Asia-Pacific Anti-infective API Consumption Value (2019-2030)
4.5 South America Anti-infective API Consumption Value (2019-2030)
4.6 Middle East and Africa Anti-infective API Consumption Value (2019-2030)

5 Market Segment by Type
5.1 Global Anti-infective API Sales Quantity by Type (2019-2030)
5.2 Global Anti-infective API Consumption Value by Type (2019-2030)
5.3 Global Anti-infective API Average Price by Type (2019-2030)

6 Market Segment by Application
6.1 Global Anti-infective API Sales Quantity by Application (2019-2030)
6.2 Global Anti-infective API Consumption Value by Application (2019-2030)
6.3 Global Anti-infective API Average Price by Application (2019-2030)

7 North America
7.1 North America Anti-infective API Sales Quantity by Type (2019-2030)
7.2 North America Anti-infective API Sales Quantity by Application (2019-2030)
7.3 North America Anti-infective API Market Size by Country
7.3.1 North America Anti-infective API Sales Quantity by Country (2019-2030)
7.3.2 North America Anti-infective API Consumption Value by Country (2019-2030)
7.3.3 United States Market Size and Forecast (2019-2030)
7.3.4 Canada Market Size and Forecast (2019-2030)
7.3.5 Mexico Market Size and Forecast (2019-2030)

8 Europe
8.1 Europe Anti-infective API Sales Quantity by Type (2019-2030)
8.2 Europe Anti-infective API Sales Quantity by Application (2019-2030)
8.3 Europe Anti-infective API Market Size by Country
8.3.1 Europe Anti-infective API Sales Quantity by Country (2019-2030)
8.3.2 Europe Anti-infective API Consumption Value by Country (2019-2030)
8.3.3 Germany Market Size and Forecast (2019-2030)
8.3.4 France Market Size and Forecast (2019-2030)
8.3.5 United Kingdom Market Size and Forecast (2019-2030)
8.3.6 Russia Market Size and Forecast (2019-2030)
8.3.7 Italy Market Size and Forecast (2019-2030)

9 Asia-Pacific
9.1 Asia-Pacific Anti-infective API Sales Quantity by Type (2019-2030)
9.2 Asia-Pacific Anti-infective API Sales Quantity by Application (2019-2030)
9.3 Asia-Pacific Anti-infective API Market Size by Region
9.3.1 Asia-Pacific Anti-infective API Sales Quantity by Region (2019-2030)
9.3.2 Asia-Pacific Anti-infective API Consumption Value by Region (2019-2030)
9.3.3 China Market Size and Forecast (2019-2030)
9.3.4 Japan Market Size and Forecast (2019-2030)
9.3.5 Korea Market Size and Forecast (2019-2030)
9.3.6 India Market Size and Forecast (2019-2030)
9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
9.3.8 Australia Market Size and Forecast (2019-2030)

10 South America
10.1 South America Anti-infective API Sales Quantity by Type (2019-2030)
10.2 South America Anti-infective API Sales Quantity by Application (2019-2030)
10.3 South America Anti-infective API Market Size by Country
10.3.1 South America Anti-infective API Sales Quantity by Country (2019-2030)
10.3.2 South America Anti-infective API Consumption Value by Country (2019-2030)
10.3.3 Brazil Market Size and Forecast (2019-2030)
10.3.4 Argentina Market Size and Forecast (2019-2030)

11 Middle East & Africa
11.1 Middle East & Africa Anti-infective API Sales Quantity by Type (2019-2030)
11.2 Middle East & Africa Anti-infective API Sales Quantity by Application (2019-2030)
11.3 Middle East & Africa Anti-infective API Market Size by Country
11.3.1 Middle East & Africa Anti-infective API Sales Quantity by Country (2019-2030)
11.3.2 Middle East & Africa Anti-infective API Consumption Value by Country (2019-2030)
11.3.3 Turkey Market Size and Forecast (2019-2030)
11.3.4 Egypt Market Size and Forecast (2019-2030)
11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
11.3.6 South Africa Market Size and Forecast (2019-2030)

12 Market Dynamics
12.1 Anti-infective API Market Drivers
12.2 Anti-infective API Market Restraints
12.3 Anti-infective API Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain
13.1 Raw Material of Anti-infective API and Key Manufacturers
13.2 Manufacturing Costs Percentage of Anti-infective API
13.3 Anti-infective API Production Process
13.4 Anti-infective API Industrial Chain

14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Anti-infective API Typical Distributors
14.3 Anti-infective API Typical Customers

15 Research Findings and Conclusion

16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
btl

Table of Figures

List of Tables
Table 1. Global Anti-infective API Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Anti-infective API Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. North China Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 4. North China Pharmaceutical Major Business
Table 5. North China Pharmaceutical Anti-infective API Product and Services
Table 6. North China Pharmaceutical Anti-infective API Sales Quantity (Kiloton), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 7. North China Pharmaceutical Recent Developments/Updates
Table 8. CSPC Basic Information, Manufacturing Base and Competitors
Table 9. CSPC Major Business
Table 10. CSPC Anti-infective API Product and Services
Table 11. CSPC Anti-infective API Sales Quantity (Kiloton), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 12. CSPC Recent Developments/Updates
Table 13. Harbin Pharmaceutical Group Pharmaceutical General Factory Basic Information, Manufacturing Base and Competitors
Table 14. Harbin Pharmaceutical Group Pharmaceutical General Factory Major Business
Table 15. Harbin Pharmaceutical Group Pharmaceutical General Factory Anti-infective API Product and Services
Table 16. Harbin Pharmaceutical Group Pharmaceutical General Factory Anti-infective API Sales Quantity (Kiloton), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 17. Harbin Pharmaceutical Group Pharmaceutical General Factory Recent Developments/Updates
Table 18. Henan Huaxing Pharmaceutical Factory Basic Information, Manufacturing Base and Competitors
Table 19. Henan Huaxing Pharmaceutical Factory Major Business
Table 20. Henan Huaxing Pharmaceutical Factory Anti-infective API Product and Services
Table 21. Henan Huaxing Pharmaceutical Factory Anti-infective API Sales Quantity (Kiloton), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 22. Henan Huaxing Pharmaceutical Factory Recent Developments/Updates
Table 23. Sichuan Pharmaceutical Jiangxi Dongfeng Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 24. Sichuan Pharmaceutical Jiangxi Dongfeng Pharmaceutical Major Business
Table 25. Sichuan Pharmaceutical Jiangxi Dongfeng Pharmaceutical Anti-infective API Product and Services
Table 26. Sichuan Pharmaceutical Jiangxi Dongfeng Pharmaceutical Anti-infective API Sales Quantity (Kiloton), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 27. Sichuan Pharmaceutical Jiangxi Dongfeng Pharmaceutical Recent Developments/Updates
Table 28. Zhangjiakou Diha Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 29. Zhangjiakou Diha Pharmaceutical Major Business
Table 30. Zhangjiakou Diha Pharmaceutical Anti-infective API Product and Services
Table 31. Zhangjiakou Diha Pharmaceutical Anti-infective API Sales Quantity (Kiloton), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 32. Zhangjiakou Diha Pharmaceutical Recent Developments/Updates
Table 33. Shandong Lukang Medicine Basic Information, Manufacturing Base and Competitors
Table 34. Shandong Lukang Medicine Major Business
Table 35. Shandong Lukang Medicine Anti-infective API Product and Services
Table 36. Shandong Lukang Medicine Anti-infective API Sales Quantity (Kiloton), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 37. Shandong Lukang Medicine Recent Developments/Updates
Table 38. Zhuhai United Laboratories Basic Information, Manufacturing Base and Competitors
Table 39. Zhuhai United Laboratories Major Business
Table 40. Zhuhai United Laboratories Anti-infective API Product and Services
Table 41. Zhuhai United Laboratories Anti-infective API Sales Quantity (Kiloton), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 42. Zhuhai United Laboratories Recent Developments/Updates
Table 43. Lunan Pharmaceutical Group Basic Information, Manufacturing Base and Competitors
Table 44. Lunan Pharmaceutical Group Major Business
Table 45. Lunan Pharmaceutical Group Anti-infective API Product and Services
Table 46. Lunan Pharmaceutical Group Anti-infective API Sales Quantity (Kiloton), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 47. Lunan Pharmaceutical Group Recent Developments/Updates
Table 48. Sandoz Basic Information, Manufacturing Base and Competitors
Table 49. Sandoz Major Business
Table 50. Sandoz Anti-infective API Product and Services
Table 51. Sandoz Anti-infective API Sales Quantity (Kiloton), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 52. Sandoz Recent Developments/Updates
Table 53. Global Anti-infective API Sales Quantity by Manufacturer (2019-2024) & (Kiloton)
Table 54. Global Anti-infective API Revenue by Manufacturer (2019-2024) & (USD Million)
Table 55. Global Anti-infective API Average Price by Manufacturer (2019-2024) & (US$/Ton)
Table 56. Market Position of Manufacturers in Anti-infective API, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2023
Table 57. Head Office and Anti-infective API Production Site of Key Manufacturer
Table 58. Anti-infective API Market: Company Product Type Footprint
Table 59. Anti-infective API Market: Company Product Application Footprint
Table 60. Anti-infective API New Market Entrants and Barriers to Market Entry
Table 61. Anti-infective API Mergers, Acquisition, Agreements, and Collaborations
Table 62. Global Anti-infective API Sales Quantity by Region (2019-2024) & (Kiloton)
Table 63. Global Anti-infective API Sales Quantity by Region (2025-2030) & (Kiloton)
Table 64. Global Anti-infective API Consumption Value by Region (2019-2024) & (USD Million)
Table 65. Global Anti-infective API Consumption Value by Region (2025-2030) & (USD Million)
Table 66. Global Anti-infective API Average Price by Region (2019-2024) & (US$/Ton)
Table 67. Global Anti-infective API Average Price by Region (2025-2030) & (US$/Ton)
Table 68. Global Anti-infective API Sales Quantity by Type (2019-2024) & (Kiloton)
Table 69. Global Anti-infective API Sales Quantity by Type (2025-2030) & (Kiloton)
Table 70. Global Anti-infective API Consumption Value by Type (2019-2024) & (USD Million)
Table 71. Global Anti-infective API Consumption Value by Type (2025-2030) & (USD Million)
Table 72. Global Anti-infective API Average Price by Type (2019-2024) & (US$/Ton)
Table 73. Global Anti-infective API Average Price by Type (2025-2030) & (US$/Ton)
Table 74. Global Anti-infective API Sales Quantity by Application (2019-2024) & (Kiloton)
Table 75. Global Anti-infective API Sales Quantity by Application (2025-2030) & (Kiloton)
Table 76. Global Anti-infective API Consumption Value by Application (2019-2024) & (USD Million)
Table 77. Global Anti-infective API Consumption Value by Application (2025-2030) & (USD Million)
Table 78. Global Anti-infective API Average Price by Application (2019-2024) & (US$/Ton)
Table 79. Global Anti-infective API Average Price by Application (2025-2030) & (US$/Ton)
Table 80. North America Anti-infective API Sales Quantity by Type (2019-2024) & (Kiloton)
Table 81. North America Anti-infective API Sales Quantity by Type (2025-2030) & (Kiloton)
Table 82. North America Anti-infective API Sales Quantity by Application (2019-2024) & (Kiloton)
Table 83. North America Anti-infective API Sales Quantity by Application (2025-2030) & (Kiloton)
Table 84. North America Anti-infective API Sales Quantity by Country (2019-2024) & (Kiloton)
Table 85. North America Anti-infective API Sales Quantity by Country (2025-2030) & (Kiloton)
Table 86. North America Anti-infective API Consumption Value by Country (2019-2024) & (USD Million)
Table 87. North America Anti-infective API Consumption Value by Country (2025-2030) & (USD Million)
Table 88. Europe Anti-infective API Sales Quantity by Type (2019-2024) & (Kiloton)
Table 89. Europe Anti-infective API Sales Quantity by Type (2025-2030) & (Kiloton)
Table 90. Europe Anti-infective API Sales Quantity by Application (2019-2024) & (Kiloton)
Table 91. Europe Anti-infective API Sales Quantity by Application (2025-2030) & (Kiloton)
Table 92. Europe Anti-infective API Sales Quantity by Country (2019-2024) & (Kiloton)
Table 93. Europe Anti-infective API Sales Quantity by Country (2025-2030) & (Kiloton)
Table 94. Europe Anti-infective API Consumption Value by Country (2019-2024) & (USD Million)
Table 95. Europe Anti-infective API Consumption Value by Country (2025-2030) & (USD Million)
Table 96. Asia-Pacific Anti-infective API Sales Quantity by Type (2019-2024) & (Kiloton)
Table 97. Asia-Pacific Anti-infective API Sales Quantity by Type (2025-2030) & (Kiloton)
Table 98. Asia-Pacific Anti-infective API Sales Quantity by Application (2019-2024) & (Kiloton)
Table 99. Asia-Pacific Anti-infective API Sales Quantity by Application (2025-2030) & (Kiloton)
Table 100. Asia-Pacific Anti-infective API Sales Quantity by Region (2019-2024) & (Kiloton)
Table 101. Asia-Pacific Anti-infective API Sales Quantity by Region (2025-2030) & (Kiloton)
Table 102. Asia-Pacific Anti-infective API Consumption Value by Region (2019-2024) & (USD Million)
Table 103. Asia-Pacific Anti-infective API Consumption Value by Region (2025-2030) & (USD Million)
Table 104. South America Anti-infective API Sales Quantity by Type (2019-2024) & (Kiloton)
Table 105. South America Anti-infective API Sales Quantity by Type (2025-2030) & (Kiloton)
Table 106. South America Anti-infective API Sales Quantity by Application (2019-2024) & (Kiloton)
Table 107. South America Anti-infective API Sales Quantity by Application (2025-2030) & (Kiloton)
Table 108. South America Anti-infective API Sales Quantity by Country (2019-2024) & (Kiloton)
Table 109. South America Anti-infective API Sales Quantity by Country (2025-2030) & (Kiloton)
Table 110. South America Anti-infective API Consumption Value by Country (2019-2024) & (USD Million)
Table 111. South America Anti-infective API Consumption Value by Country (2025-2030) & (USD Million)
Table 112. Middle East & Africa Anti-infective API Sales Quantity by Type (2019-2024) & (Kiloton)
Table 113. Middle East & Africa Anti-infective API Sales Quantity by Type (2025-2030) & (Kiloton)
Table 114. Middle East & Africa Anti-infective API Sales Quantity by Application (2019-2024) & (Kiloton)
Table 115. Middle East & Africa Anti-infective API Sales Quantity by Application (2025-2030) & (Kiloton)
Table 116. Middle East & Africa Anti-infective API Sales Quantity by Region (2019-2024) & (Kiloton)
Table 117. Middle East & Africa Anti-infective API Sales Quantity by Region (2025-2030) & (Kiloton)
Table 118. Middle East & Africa Anti-infective API Consumption Value by Region (2019-2024) & (USD Million)
Table 119. Middle East & Africa Anti-infective API Consumption Value by Region (2025-2030) & (USD Million)
Table 120. Anti-infective API Raw Material
Table 121. Key Manufacturers of Anti-infective API Raw Materials
Table 122. Anti-infective API Typical Distributors
Table 123. Anti-infective API Typical Customers
List of Figures
Figure 1. Anti-infective API Picture
Figure 2. Global Anti-infective API Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Anti-infective API Consumption Value Market Share by Type in 2023
Figure 4. β-lactam Drugs Examples
Figure 5. Macrolides Examples
Figure 6. Carbapenems Examples
Figure 7. Quinolones Examples
Figure 8. Global Anti-infective API Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 9. Global Anti-infective API Consumption Value Market Share by Application in 2023
Figure 10. Antibacterial Drugs for Systemic Use Examples
Figure 11. Antiviral Drugs for Systemic Use Examples
Figure 12. Antigen for Whole Body Examples
Figure 13. Bacteria Examples
Figure 14. Immune Serum and Immunoglobulin Examples
Figure 15. Anti-mycobacterial Drugs Examples
Figure 16. Vaccine Examples
Figure 17. Other Examples
Figure 18. Global Anti-infective API Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 19. Global Anti-infective API Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 20. Global Anti-infective API Sales Quantity (2019-2030) & (Kiloton)
Figure 21. Global Anti-infective API Average Price (2019-2030) & (US$/Ton)
Figure 22. Global Anti-infective API Sales Quantity Market Share by Manufacturer in 2023
Figure 23. Global Anti-infective API Consumption Value Market Share by Manufacturer in 2023
Figure 24. Producer Shipments of Anti-infective API by Manufacturer Sales Quantity ($MM) and Market Share (%): 2023
Figure 25. Top 3 Anti-infective API Manufacturer (Consumption Value) Market Share in 2023
Figure 26. Top 6 Anti-infective API Manufacturer (Consumption Value) Market Share in 2023
Figure 27. Global Anti-infective API Sales Quantity Market Share by Region (2019-2030)
Figure 28. Global Anti-infective API Consumption Value Market Share by Region (2019-2030)
Figure 29. North America Anti-infective API Consumption Value (2019-2030) & (USD Million)
Figure 30. Europe Anti-infective API Consumption Value (2019-2030) & (USD Million)
Figure 31. Asia-Pacific Anti-infective API Consumption Value (2019-2030) & (USD Million)
Figure 32. South America Anti-infective API Consumption Value (2019-2030) & (USD Million)
Figure 33. Middle East & Africa Anti-infective API Consumption Value (2019-2030) & (USD Million)
Figure 34. Global Anti-infective API Sales Quantity Market Share by Type (2019-2030)
Figure 35. Global Anti-infective API Consumption Value Market Share by Type (2019-2030)
Figure 36. Global Anti-infective API Average Price by Type (2019-2030) & (US$/Ton)
Figure 37. Global Anti-infective API Sales Quantity Market Share by Application (2019-2030)
Figure 38. Global Anti-infective API Consumption Value Market Share by Application (2019-2030)
Figure 39. Global Anti-infective API Average Price by Application (2019-2030) & (US$/Ton)
Figure 40. North America Anti-infective API Sales Quantity Market Share by Type (2019-2030)
Figure 41. North America Anti-infective API Sales Quantity Market Share by Application (2019-2030)
Figure 42. North America Anti-infective API Sales Quantity Market Share by Country (2019-2030)
Figure 43. North America Anti-infective API Consumption Value Market Share by Country (2019-2030)
Figure 44. United States Anti-infective API Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 45. Canada Anti-infective API Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 46. Mexico Anti-infective API Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 47. Europe Anti-infective API Sales Quantity Market Share by Type (2019-2030)
Figure 48. Europe Anti-infective API Sales Quantity Market Share by Application (2019-2030)
Figure 49. Europe Anti-infective API Sales Quantity Market Share by Country (2019-2030)
Figure 50. Europe Anti-infective API Consumption Value Market Share by Country (2019-2030)
Figure 51. Germany Anti-infective API Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 52. France Anti-infective API Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 53. United Kingdom Anti-infective API Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 54. Russia Anti-infective API Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 55. Italy Anti-infective API Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 56. Asia-Pacific Anti-infective API Sales Quantity Market Share by Type (2019-2030)
Figure 57. Asia-Pacific Anti-infective API Sales Quantity Market Share by Application (2019-2030)
Figure 58. Asia-Pacific Anti-infective API Sales Quantity Market Share by Region (2019-2030)
Figure 59. Asia-Pacific Anti-infective API Consumption Value Market Share by Region (2019-2030)
Figure 60. China Anti-infective API Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 61. Japan Anti-infective API Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 62. Korea Anti-infective API Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 63. India Anti-infective API Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 64. Southeast Asia Anti-infective API Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 65. Australia Anti-infective API Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 66. South America Anti-infective API Sales Quantity Market Share by Type (2019-2030)
Figure 67. South America Anti-infective API Sales Quantity Market Share by Application (2019-2030)
Figure 68. South America Anti-infective API Sales Quantity Market Share by Country (2019-2030)
Figure 69. South America Anti-infective API Consumption Value Market Share by Country (2019-2030)
Figure 70. Brazil Anti-infective API Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 71. Argentina Anti-infective API Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 72. Middle East & Africa Anti-infective API Sales Quantity Market Share by Type (2019-2030)
Figure 73. Middle East & Africa Anti-infective API Sales Quantity Market Share by Application (2019-2030)
Figure 74. Middle East & Africa Anti-infective API Sales Quantity Market Share by Region (2019-2030)
Figure 75. Middle East & Africa Anti-infective API Consumption Value Market Share by Region (2019-2030)
Figure 76. Turkey Anti-infective API Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 77. Egypt Anti-infective API Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 78. Saudi Arabia Anti-infective API Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 79. South Africa Anti-infective API Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 80. Anti-infective API Market Drivers
Figure 81. Anti-infective API Market Restraints
Figure 82. Anti-infective API Market Trends
Figure 83. Porters Five Forces Analysis
Figure 84. Manufacturing Cost Structure Analysis of Anti-infective API in 2023
Figure 85. Manufacturing Process Analysis of Anti-infective API
Figure 86. Anti-infective API Industrial Chain
Figure 87. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 88. Direct Channel Pros & Cons
Figure 89. Indirect Channel Pros & Cons
Figure 90. Methodology
Figure 91. Research Process and Data Source
btl

Research Methodology

Client Requirements

yuan2

Review and analyze client requirements

yuan2

Discussion of all the project requirements and queries

Flexibility Check

yuan2

Project Feasibility Analysis

yuan2

Finalizing tentative research programme

yuan2

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

yuan2

Determination of key drivers, restraints, challenge, and opportunity

yuan2

Identifies market needs and trends

Market Size Estimation & Forecast

yuan2

Estimation of historical data based on secondary and primary data

yuan2

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

yuan2

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

yuan2

Consideration of geography, region-specific product/service demand for region segments

yuan2

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

tuBiao1

Data Source

yuan2

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

yuan2

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

yuan2

Collection of data

yuan2

Cumulating and collating the essential qualitative and quantitative data

yuan2

Generation of report in client requested format by research analysts

yuan2

Reviews by expert analysts

yuan2

Final quality check

yuan2

Clarifying queries

yuan2

Receiving feedback

yuan2

Ensuring satisfaction

  • yuan01
    liuCheng01

    01 Identification of data

    This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.

  • yuan01
    liuCheng01

    02 Evaluation of Market Dynamic

    This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.

  • yuan01
    liuCheng01

    03 Collection of Data

    This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.

  • yuan01
    liuCheng01

    04 Collaboration of Data

    This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.

  • yuan01
    liuCheng01

    05 Verification and Analysis

    This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

btl

Companies Mentioned

North China Pharmaceutical
CSPC
Harbin Pharmaceutical Group Pharmaceutical General Factory
Henan Huaxing Pharmaceutical Factory
Sichuan Pharmaceutical Jiangxi Dongfeng Pharmaceutical
Zhangjiakou Diha Pharmaceutical
Shandong Lukang Medicine
Zhuhai United Laboratories
Lunan Pharmaceutical Group
Sandoz
shop_t

Purchase Options

jiaGou

Add To Cart

jiaGou

Buy Now

masterCard
visa
jcb
americanExpress
shop_b
Global Anti-infective API Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Global Anti-infective API Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Page: 115

Published Date: 08 Jan 2024

Category: Chemical & Material

PDF Download

Get FREE Sample

Customize Request

Description

arrow-d3
btl

Description

According to our (Global Info Research) latest study, the global Anti-infective API market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

The Global Info Research report includes an overview of the development of the Anti-infective API industry chain, the market status of Antibacterial Drugs for Systemic Use (β-lactam Drugs, Macrolides), Antiviral Drugs for Systemic Use (β-lactam Drugs, Macrolides), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Anti-infective API.

Regionally, the report analyzes the Anti-infective API markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Anti-infective API market, with robust domestic demand, supportive policies, and a strong manufacturing base.

Key Features:
The report presents comprehensive understanding of the Anti-infective API market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Anti-infective API industry.

The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (Kiloton), revenue generated, and market share of different by Type (e.g., β-lactam Drugs, Macrolides).

Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Anti-infective API market.

Regional Analysis: The report involves examining the Anti-infective API market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.

Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Anti-infective API market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.

The report also involves a more granular approach to Anti-infective API:
Company Analysis: Report covers individual Anti-infective API manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.

Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Anti-infective API This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Antibacterial Drugs for Systemic Use, Antiviral Drugs for Systemic Use).

Technology Analysis: Report covers specific technologies relevant to Anti-infective API. It assesses the current state, advancements, and potential future developments in Anti-infective API areas.

Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Anti-infective API market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.

Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.

Market Segmentation
Anti-infective API market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.

Market segment by Type
β-lactam Drugs
Macrolides
Carbapenems
Quinolones

Market segment by Application
Antibacterial Drugs for Systemic Use
Antiviral Drugs for Systemic Use
Antigen for Whole Body
Bacteria
Immune Serum and Immunoglobulin
Anti-mycobacterial Drugs
Vaccine
Other

Major players covered
North China Pharmaceutical
CSPC
Harbin Pharmaceutical Group Pharmaceutical General Factory
Henan Huaxing Pharmaceutical Factory
Sichuan Pharmaceutical Jiangxi Dongfeng Pharmaceutical
Zhangjiakou Diha Pharmaceutical
Shandong Lukang Medicine
Zhuhai United Laboratories
Lunan Pharmaceutical Group
Sandoz

Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Anti-infective API product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Anti-infective API, with price, sales, revenue and global market share of Anti-infective API from 2019 to 2024.
Chapter 3, the Anti-infective API competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Anti-infective API breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Anti-infective API market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Anti-infective API.
Chapter 14 and 15, to describe Anti-infective API sales channel, distributors, customers, research findings and conclusion.
btl

Table of Contents

1 Market Overview
1.1 Product Overview and Scope of Anti-infective API
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Anti-infective API Consumption Value by Type: 2019 Versus 2023 Versus 2030
1.3.2 β-lactam Drugs
1.3.3 Macrolides
1.3.4 Carbapenems
1.3.5 Quinolones
1.4 Market Analysis by Application
1.4.1 Overview: Global Anti-infective API Consumption Value by Application: 2019 Versus 2023 Versus 2030
1.4.2 Antibacterial Drugs for Systemic Use
1.4.3 Antiviral Drugs for Systemic Use
1.4.4 Antigen for Whole Body
1.4.5 Bacteria
1.4.6 Immune Serum and Immunoglobulin
1.4.7 Anti-mycobacterial Drugs
1.4.8 Vaccine
1.4.9 Other
1.5 Global Anti-infective API Market Size & Forecast
1.5.1 Global Anti-infective API Consumption Value (2019 & 2023 & 2030)
1.5.2 Global Anti-infective API Sales Quantity (2019-2030)
1.5.3 Global Anti-infective API Average Price (2019-2030)

2 Manufacturers Profiles
2.1 North China Pharmaceutical
2.1.1 North China Pharmaceutical Details
2.1.2 North China Pharmaceutical Major Business
2.1.3 North China Pharmaceutical Anti-infective API Product and Services
2.1.4 North China Pharmaceutical Anti-infective API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 North China Pharmaceutical Recent Developments/Updates
2.2 CSPC
2.2.1 CSPC Details
2.2.2 CSPC Major Business
2.2.3 CSPC Anti-infective API Product and Services
2.2.4 CSPC Anti-infective API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 CSPC Recent Developments/Updates
2.3 Harbin Pharmaceutical Group Pharmaceutical General Factory
2.3.1 Harbin Pharmaceutical Group Pharmaceutical General Factory Details
2.3.2 Harbin Pharmaceutical Group Pharmaceutical General Factory Major Business
2.3.3 Harbin Pharmaceutical Group Pharmaceutical General Factory Anti-infective API Product and Services
2.3.4 Harbin Pharmaceutical Group Pharmaceutical General Factory Anti-infective API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Harbin Pharmaceutical Group Pharmaceutical General Factory Recent Developments/Updates
2.4 Henan Huaxing Pharmaceutical Factory
2.4.1 Henan Huaxing Pharmaceutical Factory Details
2.4.2 Henan Huaxing Pharmaceutical Factory Major Business
2.4.3 Henan Huaxing Pharmaceutical Factory Anti-infective API Product and Services
2.4.4 Henan Huaxing Pharmaceutical Factory Anti-infective API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Henan Huaxing Pharmaceutical Factory Recent Developments/Updates
2.5 Sichuan Pharmaceutical Jiangxi Dongfeng Pharmaceutical
2.5.1 Sichuan Pharmaceutical Jiangxi Dongfeng Pharmaceutical Details
2.5.2 Sichuan Pharmaceutical Jiangxi Dongfeng Pharmaceutical Major Business
2.5.3 Sichuan Pharmaceutical Jiangxi Dongfeng Pharmaceutical Anti-infective API Product and Services
2.5.4 Sichuan Pharmaceutical Jiangxi Dongfeng Pharmaceutical Anti-infective API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Sichuan Pharmaceutical Jiangxi Dongfeng Pharmaceutical Recent Developments/Updates
2.6 Zhangjiakou Diha Pharmaceutical
2.6.1 Zhangjiakou Diha Pharmaceutical Details
2.6.2 Zhangjiakou Diha Pharmaceutical Major Business
2.6.3 Zhangjiakou Diha Pharmaceutical Anti-infective API Product and Services
2.6.4 Zhangjiakou Diha Pharmaceutical Anti-infective API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Zhangjiakou Diha Pharmaceutical Recent Developments/Updates
2.7 Shandong Lukang Medicine
2.7.1 Shandong Lukang Medicine Details
2.7.2 Shandong Lukang Medicine Major Business
2.7.3 Shandong Lukang Medicine Anti-infective API Product and Services
2.7.4 Shandong Lukang Medicine Anti-infective API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Shandong Lukang Medicine Recent Developments/Updates
2.8 Zhuhai United Laboratories
2.8.1 Zhuhai United Laboratories Details
2.8.2 Zhuhai United Laboratories Major Business
2.8.3 Zhuhai United Laboratories Anti-infective API Product and Services
2.8.4 Zhuhai United Laboratories Anti-infective API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Zhuhai United Laboratories Recent Developments/Updates
2.9 Lunan Pharmaceutical Group
2.9.1 Lunan Pharmaceutical Group Details
2.9.2 Lunan Pharmaceutical Group Major Business
2.9.3 Lunan Pharmaceutical Group Anti-infective API Product and Services
2.9.4 Lunan Pharmaceutical Group Anti-infective API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Lunan Pharmaceutical Group Recent Developments/Updates
2.10 Sandoz
2.10.1 Sandoz Details
2.10.2 Sandoz Major Business
2.10.3 Sandoz Anti-infective API Product and Services
2.10.4 Sandoz Anti-infective API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 Sandoz Recent Developments/Updates

3 Competitive Environment: Anti-infective API by Manufacturer
3.1 Global Anti-infective API Sales Quantity by Manufacturer (2019-2024)
3.2 Global Anti-infective API Revenue by Manufacturer (2019-2024)
3.3 Global Anti-infective API Average Price by Manufacturer (2019-2024)
3.4 Market Share Analysis (2023)
3.4.1 Producer Shipments of Anti-infective API by Manufacturer Revenue ($MM) and Market Share (%): 2023
3.4.2 Top 3 Anti-infective API Manufacturer Market Share in 2023
3.4.2 Top 6 Anti-infective API Manufacturer Market Share in 2023
3.5 Anti-infective API Market: Overall Company Footprint Analysis
3.5.1 Anti-infective API Market: Region Footprint
3.5.2 Anti-infective API Market: Company Product Type Footprint
3.5.3 Anti-infective API Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region
4.1 Global Anti-infective API Market Size by Region
4.1.1 Global Anti-infective API Sales Quantity by Region (2019-2030)
4.1.2 Global Anti-infective API Consumption Value by Region (2019-2030)
4.1.3 Global Anti-infective API Average Price by Region (2019-2030)
4.2 North America Anti-infective API Consumption Value (2019-2030)
4.3 Europe Anti-infective API Consumption Value (2019-2030)
4.4 Asia-Pacific Anti-infective API Consumption Value (2019-2030)
4.5 South America Anti-infective API Consumption Value (2019-2030)
4.6 Middle East and Africa Anti-infective API Consumption Value (2019-2030)

5 Market Segment by Type
5.1 Global Anti-infective API Sales Quantity by Type (2019-2030)
5.2 Global Anti-infective API Consumption Value by Type (2019-2030)
5.3 Global Anti-infective API Average Price by Type (2019-2030)

6 Market Segment by Application
6.1 Global Anti-infective API Sales Quantity by Application (2019-2030)
6.2 Global Anti-infective API Consumption Value by Application (2019-2030)
6.3 Global Anti-infective API Average Price by Application (2019-2030)

7 North America
7.1 North America Anti-infective API Sales Quantity by Type (2019-2030)
7.2 North America Anti-infective API Sales Quantity by Application (2019-2030)
7.3 North America Anti-infective API Market Size by Country
7.3.1 North America Anti-infective API Sales Quantity by Country (2019-2030)
7.3.2 North America Anti-infective API Consumption Value by Country (2019-2030)
7.3.3 United States Market Size and Forecast (2019-2030)
7.3.4 Canada Market Size and Forecast (2019-2030)
7.3.5 Mexico Market Size and Forecast (2019-2030)

8 Europe
8.1 Europe Anti-infective API Sales Quantity by Type (2019-2030)
8.2 Europe Anti-infective API Sales Quantity by Application (2019-2030)
8.3 Europe Anti-infective API Market Size by Country
8.3.1 Europe Anti-infective API Sales Quantity by Country (2019-2030)
8.3.2 Europe Anti-infective API Consumption Value by Country (2019-2030)
8.3.3 Germany Market Size and Forecast (2019-2030)
8.3.4 France Market Size and Forecast (2019-2030)
8.3.5 United Kingdom Market Size and Forecast (2019-2030)
8.3.6 Russia Market Size and Forecast (2019-2030)
8.3.7 Italy Market Size and Forecast (2019-2030)

9 Asia-Pacific
9.1 Asia-Pacific Anti-infective API Sales Quantity by Type (2019-2030)
9.2 Asia-Pacific Anti-infective API Sales Quantity by Application (2019-2030)
9.3 Asia-Pacific Anti-infective API Market Size by Region
9.3.1 Asia-Pacific Anti-infective API Sales Quantity by Region (2019-2030)
9.3.2 Asia-Pacific Anti-infective API Consumption Value by Region (2019-2030)
9.3.3 China Market Size and Forecast (2019-2030)
9.3.4 Japan Market Size and Forecast (2019-2030)
9.3.5 Korea Market Size and Forecast (2019-2030)
9.3.6 India Market Size and Forecast (2019-2030)
9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
9.3.8 Australia Market Size and Forecast (2019-2030)

10 South America
10.1 South America Anti-infective API Sales Quantity by Type (2019-2030)
10.2 South America Anti-infective API Sales Quantity by Application (2019-2030)
10.3 South America Anti-infective API Market Size by Country
10.3.1 South America Anti-infective API Sales Quantity by Country (2019-2030)
10.3.2 South America Anti-infective API Consumption Value by Country (2019-2030)
10.3.3 Brazil Market Size and Forecast (2019-2030)
10.3.4 Argentina Market Size and Forecast (2019-2030)

11 Middle East & Africa
11.1 Middle East & Africa Anti-infective API Sales Quantity by Type (2019-2030)
11.2 Middle East & Africa Anti-infective API Sales Quantity by Application (2019-2030)
11.3 Middle East & Africa Anti-infective API Market Size by Country
11.3.1 Middle East & Africa Anti-infective API Sales Quantity by Country (2019-2030)
11.3.2 Middle East & Africa Anti-infective API Consumption Value by Country (2019-2030)
11.3.3 Turkey Market Size and Forecast (2019-2030)
11.3.4 Egypt Market Size and Forecast (2019-2030)
11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
11.3.6 South Africa Market Size and Forecast (2019-2030)

12 Market Dynamics
12.1 Anti-infective API Market Drivers
12.2 Anti-infective API Market Restraints
12.3 Anti-infective API Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain
13.1 Raw Material of Anti-infective API and Key Manufacturers
13.2 Manufacturing Costs Percentage of Anti-infective API
13.3 Anti-infective API Production Process
13.4 Anti-infective API Industrial Chain

14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Anti-infective API Typical Distributors
14.3 Anti-infective API Typical Customers

15 Research Findings and Conclusion

16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
btl

Table of Figures

List of Tables
Table 1. Global Anti-infective API Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Anti-infective API Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. North China Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 4. North China Pharmaceutical Major Business
Table 5. North China Pharmaceutical Anti-infective API Product and Services
Table 6. North China Pharmaceutical Anti-infective API Sales Quantity (Kiloton), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 7. North China Pharmaceutical Recent Developments/Updates
Table 8. CSPC Basic Information, Manufacturing Base and Competitors
Table 9. CSPC Major Business
Table 10. CSPC Anti-infective API Product and Services
Table 11. CSPC Anti-infective API Sales Quantity (Kiloton), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 12. CSPC Recent Developments/Updates
Table 13. Harbin Pharmaceutical Group Pharmaceutical General Factory Basic Information, Manufacturing Base and Competitors
Table 14. Harbin Pharmaceutical Group Pharmaceutical General Factory Major Business
Table 15. Harbin Pharmaceutical Group Pharmaceutical General Factory Anti-infective API Product and Services
Table 16. Harbin Pharmaceutical Group Pharmaceutical General Factory Anti-infective API Sales Quantity (Kiloton), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 17. Harbin Pharmaceutical Group Pharmaceutical General Factory Recent Developments/Updates
Table 18. Henan Huaxing Pharmaceutical Factory Basic Information, Manufacturing Base and Competitors
Table 19. Henan Huaxing Pharmaceutical Factory Major Business
Table 20. Henan Huaxing Pharmaceutical Factory Anti-infective API Product and Services
Table 21. Henan Huaxing Pharmaceutical Factory Anti-infective API Sales Quantity (Kiloton), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 22. Henan Huaxing Pharmaceutical Factory Recent Developments/Updates
Table 23. Sichuan Pharmaceutical Jiangxi Dongfeng Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 24. Sichuan Pharmaceutical Jiangxi Dongfeng Pharmaceutical Major Business
Table 25. Sichuan Pharmaceutical Jiangxi Dongfeng Pharmaceutical Anti-infective API Product and Services
Table 26. Sichuan Pharmaceutical Jiangxi Dongfeng Pharmaceutical Anti-infective API Sales Quantity (Kiloton), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 27. Sichuan Pharmaceutical Jiangxi Dongfeng Pharmaceutical Recent Developments/Updates
Table 28. Zhangjiakou Diha Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 29. Zhangjiakou Diha Pharmaceutical Major Business
Table 30. Zhangjiakou Diha Pharmaceutical Anti-infective API Product and Services
Table 31. Zhangjiakou Diha Pharmaceutical Anti-infective API Sales Quantity (Kiloton), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 32. Zhangjiakou Diha Pharmaceutical Recent Developments/Updates
Table 33. Shandong Lukang Medicine Basic Information, Manufacturing Base and Competitors
Table 34. Shandong Lukang Medicine Major Business
Table 35. Shandong Lukang Medicine Anti-infective API Product and Services
Table 36. Shandong Lukang Medicine Anti-infective API Sales Quantity (Kiloton), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 37. Shandong Lukang Medicine Recent Developments/Updates
Table 38. Zhuhai United Laboratories Basic Information, Manufacturing Base and Competitors
Table 39. Zhuhai United Laboratories Major Business
Table 40. Zhuhai United Laboratories Anti-infective API Product and Services
Table 41. Zhuhai United Laboratories Anti-infective API Sales Quantity (Kiloton), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 42. Zhuhai United Laboratories Recent Developments/Updates
Table 43. Lunan Pharmaceutical Group Basic Information, Manufacturing Base and Competitors
Table 44. Lunan Pharmaceutical Group Major Business
Table 45. Lunan Pharmaceutical Group Anti-infective API Product and Services
Table 46. Lunan Pharmaceutical Group Anti-infective API Sales Quantity (Kiloton), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 47. Lunan Pharmaceutical Group Recent Developments/Updates
Table 48. Sandoz Basic Information, Manufacturing Base and Competitors
Table 49. Sandoz Major Business
Table 50. Sandoz Anti-infective API Product and Services
Table 51. Sandoz Anti-infective API Sales Quantity (Kiloton), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 52. Sandoz Recent Developments/Updates
Table 53. Global Anti-infective API Sales Quantity by Manufacturer (2019-2024) & (Kiloton)
Table 54. Global Anti-infective API Revenue by Manufacturer (2019-2024) & (USD Million)
Table 55. Global Anti-infective API Average Price by Manufacturer (2019-2024) & (US$/Ton)
Table 56. Market Position of Manufacturers in Anti-infective API, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2023
Table 57. Head Office and Anti-infective API Production Site of Key Manufacturer
Table 58. Anti-infective API Market: Company Product Type Footprint
Table 59. Anti-infective API Market: Company Product Application Footprint
Table 60. Anti-infective API New Market Entrants and Barriers to Market Entry
Table 61. Anti-infective API Mergers, Acquisition, Agreements, and Collaborations
Table 62. Global Anti-infective API Sales Quantity by Region (2019-2024) & (Kiloton)
Table 63. Global Anti-infective API Sales Quantity by Region (2025-2030) & (Kiloton)
Table 64. Global Anti-infective API Consumption Value by Region (2019-2024) & (USD Million)
Table 65. Global Anti-infective API Consumption Value by Region (2025-2030) & (USD Million)
Table 66. Global Anti-infective API Average Price by Region (2019-2024) & (US$/Ton)
Table 67. Global Anti-infective API Average Price by Region (2025-2030) & (US$/Ton)
Table 68. Global Anti-infective API Sales Quantity by Type (2019-2024) & (Kiloton)
Table 69. Global Anti-infective API Sales Quantity by Type (2025-2030) & (Kiloton)
Table 70. Global Anti-infective API Consumption Value by Type (2019-2024) & (USD Million)
Table 71. Global Anti-infective API Consumption Value by Type (2025-2030) & (USD Million)
Table 72. Global Anti-infective API Average Price by Type (2019-2024) & (US$/Ton)
Table 73. Global Anti-infective API Average Price by Type (2025-2030) & (US$/Ton)
Table 74. Global Anti-infective API Sales Quantity by Application (2019-2024) & (Kiloton)
Table 75. Global Anti-infective API Sales Quantity by Application (2025-2030) & (Kiloton)
Table 76. Global Anti-infective API Consumption Value by Application (2019-2024) & (USD Million)
Table 77. Global Anti-infective API Consumption Value by Application (2025-2030) & (USD Million)
Table 78. Global Anti-infective API Average Price by Application (2019-2024) & (US$/Ton)
Table 79. Global Anti-infective API Average Price by Application (2025-2030) & (US$/Ton)
Table 80. North America Anti-infective API Sales Quantity by Type (2019-2024) & (Kiloton)
Table 81. North America Anti-infective API Sales Quantity by Type (2025-2030) & (Kiloton)
Table 82. North America Anti-infective API Sales Quantity by Application (2019-2024) & (Kiloton)
Table 83. North America Anti-infective API Sales Quantity by Application (2025-2030) & (Kiloton)
Table 84. North America Anti-infective API Sales Quantity by Country (2019-2024) & (Kiloton)
Table 85. North America Anti-infective API Sales Quantity by Country (2025-2030) & (Kiloton)
Table 86. North America Anti-infective API Consumption Value by Country (2019-2024) & (USD Million)
Table 87. North America Anti-infective API Consumption Value by Country (2025-2030) & (USD Million)
Table 88. Europe Anti-infective API Sales Quantity by Type (2019-2024) & (Kiloton)
Table 89. Europe Anti-infective API Sales Quantity by Type (2025-2030) & (Kiloton)
Table 90. Europe Anti-infective API Sales Quantity by Application (2019-2024) & (Kiloton)
Table 91. Europe Anti-infective API Sales Quantity by Application (2025-2030) & (Kiloton)
Table 92. Europe Anti-infective API Sales Quantity by Country (2019-2024) & (Kiloton)
Table 93. Europe Anti-infective API Sales Quantity by Country (2025-2030) & (Kiloton)
Table 94. Europe Anti-infective API Consumption Value by Country (2019-2024) & (USD Million)
Table 95. Europe Anti-infective API Consumption Value by Country (2025-2030) & (USD Million)
Table 96. Asia-Pacific Anti-infective API Sales Quantity by Type (2019-2024) & (Kiloton)
Table 97. Asia-Pacific Anti-infective API Sales Quantity by Type (2025-2030) & (Kiloton)
Table 98. Asia-Pacific Anti-infective API Sales Quantity by Application (2019-2024) & (Kiloton)
Table 99. Asia-Pacific Anti-infective API Sales Quantity by Application (2025-2030) & (Kiloton)
Table 100. Asia-Pacific Anti-infective API Sales Quantity by Region (2019-2024) & (Kiloton)
Table 101. Asia-Pacific Anti-infective API Sales Quantity by Region (2025-2030) & (Kiloton)
Table 102. Asia-Pacific Anti-infective API Consumption Value by Region (2019-2024) & (USD Million)
Table 103. Asia-Pacific Anti-infective API Consumption Value by Region (2025-2030) & (USD Million)
Table 104. South America Anti-infective API Sales Quantity by Type (2019-2024) & (Kiloton)
Table 105. South America Anti-infective API Sales Quantity by Type (2025-2030) & (Kiloton)
Table 106. South America Anti-infective API Sales Quantity by Application (2019-2024) & (Kiloton)
Table 107. South America Anti-infective API Sales Quantity by Application (2025-2030) & (Kiloton)
Table 108. South America Anti-infective API Sales Quantity by Country (2019-2024) & (Kiloton)
Table 109. South America Anti-infective API Sales Quantity by Country (2025-2030) & (Kiloton)
Table 110. South America Anti-infective API Consumption Value by Country (2019-2024) & (USD Million)
Table 111. South America Anti-infective API Consumption Value by Country (2025-2030) & (USD Million)
Table 112. Middle East & Africa Anti-infective API Sales Quantity by Type (2019-2024) & (Kiloton)
Table 113. Middle East & Africa Anti-infective API Sales Quantity by Type (2025-2030) & (Kiloton)
Table 114. Middle East & Africa Anti-infective API Sales Quantity by Application (2019-2024) & (Kiloton)
Table 115. Middle East & Africa Anti-infective API Sales Quantity by Application (2025-2030) & (Kiloton)
Table 116. Middle East & Africa Anti-infective API Sales Quantity by Region (2019-2024) & (Kiloton)
Table 117. Middle East & Africa Anti-infective API Sales Quantity by Region (2025-2030) & (Kiloton)
Table 118. Middle East & Africa Anti-infective API Consumption Value by Region (2019-2024) & (USD Million)
Table 119. Middle East & Africa Anti-infective API Consumption Value by Region (2025-2030) & (USD Million)
Table 120. Anti-infective API Raw Material
Table 121. Key Manufacturers of Anti-infective API Raw Materials
Table 122. Anti-infective API Typical Distributors
Table 123. Anti-infective API Typical Customers
List of Figures
Figure 1. Anti-infective API Picture
Figure 2. Global Anti-infective API Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Anti-infective API Consumption Value Market Share by Type in 2023
Figure 4. β-lactam Drugs Examples
Figure 5. Macrolides Examples
Figure 6. Carbapenems Examples
Figure 7. Quinolones Examples
Figure 8. Global Anti-infective API Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 9. Global Anti-infective API Consumption Value Market Share by Application in 2023
Figure 10. Antibacterial Drugs for Systemic Use Examples
Figure 11. Antiviral Drugs for Systemic Use Examples
Figure 12. Antigen for Whole Body Examples
Figure 13. Bacteria Examples
Figure 14. Immune Serum and Immunoglobulin Examples
Figure 15. Anti-mycobacterial Drugs Examples
Figure 16. Vaccine Examples
Figure 17. Other Examples
Figure 18. Global Anti-infective API Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 19. Global Anti-infective API Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 20. Global Anti-infective API Sales Quantity (2019-2030) & (Kiloton)
Figure 21. Global Anti-infective API Average Price (2019-2030) & (US$/Ton)
Figure 22. Global Anti-infective API Sales Quantity Market Share by Manufacturer in 2023
Figure 23. Global Anti-infective API Consumption Value Market Share by Manufacturer in 2023
Figure 24. Producer Shipments of Anti-infective API by Manufacturer Sales Quantity ($MM) and Market Share (%): 2023
Figure 25. Top 3 Anti-infective API Manufacturer (Consumption Value) Market Share in 2023
Figure 26. Top 6 Anti-infective API Manufacturer (Consumption Value) Market Share in 2023
Figure 27. Global Anti-infective API Sales Quantity Market Share by Region (2019-2030)
Figure 28. Global Anti-infective API Consumption Value Market Share by Region (2019-2030)
Figure 29. North America Anti-infective API Consumption Value (2019-2030) & (USD Million)
Figure 30. Europe Anti-infective API Consumption Value (2019-2030) & (USD Million)
Figure 31. Asia-Pacific Anti-infective API Consumption Value (2019-2030) & (USD Million)
Figure 32. South America Anti-infective API Consumption Value (2019-2030) & (USD Million)
Figure 33. Middle East & Africa Anti-infective API Consumption Value (2019-2030) & (USD Million)
Figure 34. Global Anti-infective API Sales Quantity Market Share by Type (2019-2030)
Figure 35. Global Anti-infective API Consumption Value Market Share by Type (2019-2030)
Figure 36. Global Anti-infective API Average Price by Type (2019-2030) & (US$/Ton)
Figure 37. Global Anti-infective API Sales Quantity Market Share by Application (2019-2030)
Figure 38. Global Anti-infective API Consumption Value Market Share by Application (2019-2030)
Figure 39. Global Anti-infective API Average Price by Application (2019-2030) & (US$/Ton)
Figure 40. North America Anti-infective API Sales Quantity Market Share by Type (2019-2030)
Figure 41. North America Anti-infective API Sales Quantity Market Share by Application (2019-2030)
Figure 42. North America Anti-infective API Sales Quantity Market Share by Country (2019-2030)
Figure 43. North America Anti-infective API Consumption Value Market Share by Country (2019-2030)
Figure 44. United States Anti-infective API Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 45. Canada Anti-infective API Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 46. Mexico Anti-infective API Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 47. Europe Anti-infective API Sales Quantity Market Share by Type (2019-2030)
Figure 48. Europe Anti-infective API Sales Quantity Market Share by Application (2019-2030)
Figure 49. Europe Anti-infective API Sales Quantity Market Share by Country (2019-2030)
Figure 50. Europe Anti-infective API Consumption Value Market Share by Country (2019-2030)
Figure 51. Germany Anti-infective API Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 52. France Anti-infective API Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 53. United Kingdom Anti-infective API Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 54. Russia Anti-infective API Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 55. Italy Anti-infective API Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 56. Asia-Pacific Anti-infective API Sales Quantity Market Share by Type (2019-2030)
Figure 57. Asia-Pacific Anti-infective API Sales Quantity Market Share by Application (2019-2030)
Figure 58. Asia-Pacific Anti-infective API Sales Quantity Market Share by Region (2019-2030)
Figure 59. Asia-Pacific Anti-infective API Consumption Value Market Share by Region (2019-2030)
Figure 60. China Anti-infective API Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 61. Japan Anti-infective API Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 62. Korea Anti-infective API Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 63. India Anti-infective API Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 64. Southeast Asia Anti-infective API Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 65. Australia Anti-infective API Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 66. South America Anti-infective API Sales Quantity Market Share by Type (2019-2030)
Figure 67. South America Anti-infective API Sales Quantity Market Share by Application (2019-2030)
Figure 68. South America Anti-infective API Sales Quantity Market Share by Country (2019-2030)
Figure 69. South America Anti-infective API Consumption Value Market Share by Country (2019-2030)
Figure 70. Brazil Anti-infective API Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 71. Argentina Anti-infective API Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 72. Middle East & Africa Anti-infective API Sales Quantity Market Share by Type (2019-2030)
Figure 73. Middle East & Africa Anti-infective API Sales Quantity Market Share by Application (2019-2030)
Figure 74. Middle East & Africa Anti-infective API Sales Quantity Market Share by Region (2019-2030)
Figure 75. Middle East & Africa Anti-infective API Consumption Value Market Share by Region (2019-2030)
Figure 76. Turkey Anti-infective API Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 77. Egypt Anti-infective API Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 78. Saudi Arabia Anti-infective API Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 79. South Africa Anti-infective API Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 80. Anti-infective API Market Drivers
Figure 81. Anti-infective API Market Restraints
Figure 82. Anti-infective API Market Trends
Figure 83. Porters Five Forces Analysis
Figure 84. Manufacturing Cost Structure Analysis of Anti-infective API in 2023
Figure 85. Manufacturing Process Analysis of Anti-infective API
Figure 86. Anti-infective API Industrial Chain
Figure 87. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 88. Direct Channel Pros & Cons
Figure 89. Indirect Channel Pros & Cons
Figure 90. Methodology
Figure 91. Research Process and Data Source
btl

Research Methodology

Client Requirements

yuan2

Review and analyze client requirements

yuan2

Discussion of all the project requirements and queries

Flexibility Check

yuan2

Project Feasibility Analysis

yuan2

Finalizing tentative research programme

yuan2

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

yuan2

Determination of key drivers, restraints, challenge, and opportunity

yuan2

Identifies market needs and trends

Market Size Estimation & Forecast

yuan2

Estimation of historical data based on secondary and primary data

yuan2

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

yuan2

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

yuan2

Consideration of geography, region-specific product/service demand for region segments

yuan2

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

tuBiao1

Data Source

yuan2

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

yuan2

Discussion of all the project requirements and queries

Validation and triangulation of secondary and primary source.

yuan2

Collection of data

yuan2

Cumulating and collating the essential qualitative and quantitative data

yuan2

Generation of report in client requested format by research analysts

yuan2

Reviews by expert analysts

yuan2

Final quality check

yuan2

Clarifying queries

yuan2

Receiving feedback

yuan2

Ensuring satisfaction

  • yuan01
    liuCheng01

    01 Identification of data

    This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.

  • yuan01
    liuCheng01

    02 Evaluation of Market Dynamic

    This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.

  • yuan01
    liuCheng01

    03 Collection of Data

    This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.

  • yuan01
    liuCheng01

    04 Collaboration of Data

    This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.

  • yuan01
    liuCheng01

    05 Verification and Analysis

    This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

btl

Companies Mentioned

North China Pharmaceutical
CSPC
Harbin Pharmaceutical Group Pharmaceutical General Factory
Henan Huaxing Pharmaceutical Factory
Sichuan Pharmaceutical Jiangxi Dongfeng Pharmaceutical
Zhangjiakou Diha Pharmaceutical
Shandong Lukang Medicine
Zhuhai United Laboratories
Lunan Pharmaceutical Group
Sandoz
jiaGou

Add To Cart

gouMai

Buy Now